Emily Hong

Emily Hong is a Clinical Trials Manager at Adagio Medical Inc., where responsibilities include serving as the main point of contact for communication with ICON (CRO) and FCEs, as well as collaborating with the clinical team to manage study documentation. Previously, Emily held positions as a Clinical Trial Associate at Kato Pharmaceuticals, managing communications with clinical sites and conducting site visits. Prior experience also includes a role as a Clinical Research Coordinator at Kahala Biosciences Inc., where Emily executed COVID-19 testing events and assisted in IRB submissions. Emily's earlier roles include research and policy internships and facilitating discussions on HIV/AIDS at UC Irvine. Emily holds a Bachelor's degree in Public Health from UC Irvine and an IB Diploma from Western Academy of Beijing.